# Annaly Capital Management Inc: Form 10-K for the period ended Dec 31, 2018

- Company: [Annaly Capital Management Inc](/companies/nly.md) (CIK 1043219)
- Form: 10-K
- Filed: 2019-02-15
- Accepted by EDGAR: Feb 14, 2019, 22:01 ET
- Period: 2018-12-31
- Accession: 0001628280-19-001442
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1043219/000162828019001442/a2018nly10-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1043219/000162828019001442/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Interest expense | 3 months, 2018-10-01 to 2018-12-31 | $586.8m | us-gaap:InterestExpense |
| Interest expense | 12 months, 2018-01-01 to 2018-12-31 | $1.90bn | us-gaap:InterestExpense |
| Income tax | 3 months, 2018-10-01 to 2018-12-31 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 12 months, 2018-01-01 to 2018-12-31 | −$2.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-10-01 to 2018-12-31 | −$2.25bn | us-gaap:ProfitLoss |
| Net income | 12 months, 2018-01-01 to 2018-12-31 | $54.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-10-01 to 2018-12-31 | −$1.74 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months, 2018-01-01 to 2018-12-31 | −$0.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-10-01 to 2018-12-31 | −$1.74 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months, 2018-01-01 to 2018-12-31 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2018-01-01 to 2018-12-31 | 1,209,601,809 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2018-01-01 to 2018-12-31 | $2.62bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months, 2018-01-01 to 2018-12-31 | $394.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2018-01-01 to 2018-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-12-31 | $1.74bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2018-12-31 | $105.79bn | us-gaap:Assets |
| Total liabilities | at 2018-12-31 | $91.67bn | us-gaap:Liabilities |
| Shareholders' equity | at 2018-12-31 | $14.11bn | us-gaap:StockholdersEquity |

## Properties

As filed, 456 characters.

Our executive and administrative office is located at 1211 Avenue of the Americas New York, New York 10036, telephone 212-696-0100. This office is leased under a non-cancelable lease expiring September 30, 2025.

For a description of the commercial real estate properties we own as part of our investment portfolio, refer to the section titled “Schedule III – Real Estate and Accumulated Depreciation” of Item 15. “Exhibits, Financial Statement Schedules.”

## Legal proceedings

As filed, 197 characters.

From time to time, we are involved in various claims and legal actions arising in the ordinary course of business. At December 31, 2018, we were not party to any pending material legal proceedings.

## Management's discussion and analysis

As filed, 11,765 characters.

### Results of Operations

The results of our operations are affected by various factors, many of which are beyond our control. Certain of such risks and uncertainties are described herein (see “Special Note Regarding Forward-Looking Statements” above) and in Part I, Item 1A. “Risk Factors”.

This Management Discussion and Analysis section contains analysis and discussion of financial results computed in accordance with U.S. generally accepted accounting principles (“GAAP”) and non-GAAP measurements. To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, we provide non-GAAP financial measures to enhance investor understanding of our period-over-period operating performance and business trends, as well as for assessing our performance versus that of industry peers.

Please refer to the “Non-GAAP Financial Measures” section for additional information.

### Net Income (Loss) Summary

The following table presents financial information related to our results of operations as of and for the years ended December 31, 2018, 2017 and 2016.

*(dollars in thousands, except per share data)*

|  | As of and for the Years Ended December 31, 2018 | 2017 | 2016 |
| --- | ---: | ---: | ---: |
| Interest income | **$3,332,563** | $2,493,126 | $2,210,951 |
| Interest expense | **1,897,860** | 1,008,354 | 657,752 |
| **Net interest income** | **1,434,703** | 1,484,772 | 1,553,199 |
| Realized and unrealized gains (losses) | **(1,162,984)** | 199,493 | 84,204 |
| Other income (loss) | **109,927** | 115,857 | 44,144 |
| Less: General and administrative expenses | **329,873** | 224,124 | 250,356 |
| **Income (loss) before income taxes** | **51,773** | 1,575,998 | 1,431,191 |
| **Income taxes** | **(2,375)** | 6,982 | (1,595) |
| **Net income (loss)** | **54,148** | 1,569,016 | 1,432,786 |
| **Less: Net income (loss) attributable to noncontrolling interests** | **(260)** | (588) | (970) |
| **Net income (loss) attributable to Annaly** | **54,408** | 1,569,604 | 1,433,756 |
| **Less: Dividends on preferred stock** | **129,312** | 109,635 | 82,260 |
| **Net income (loss) available (related) to common stockholders** | **$(74,904)** | $1,459,969 | $1,351,496 |
| **Net income (loss) per share available (related) to common stockholders** |  |  |  |
| **Basic** | **$(0.06)** | $1.37 | $1.39 |
| **Diluted** | **$(0.06)** | $1.37 | $1.39 |
| **Weighted average number of common shares outstanding** |  |  |  |
| **Basic** | **1,209,601,809** | 1,065,923,652 | 969,787,583 |
| **Diluted** | **1,209,601,809** | 1,066,351,616 | 970,102,353 |
| **Other information** |  |  |  |
| Asset portfolio at period-end | **$102,340,249** | $99,935,666 | $85,364,917 |
| Average total assets | **$102,544,922** | $91,374,962 | $81,033,136 |
| Average equity | **$14,332,404** | $13,371,907 | $12,192,715 |
| Leverage at period-end (1) | **6.3:1** | 5.7:1 | 5.8:1 |
| Economic leverage at period-end (2) | **7.0:1** | 6.6:1 | 6.4:1 |
| Capital ratio (3) | **12.1%** | 12.9% | 13.1% |
| Annualized return on average total assets | **0.05%** | 1.72% | 1.77% |
| Annualized return on average equity | **0.38%** | 11.73% | 11.75% |
| Annualized core return on average equity (excluding PAA) (4) | **10.99%** | 10.54% | 9.96% |
| Net interest margin (5) | **1.57%** | 1.38% | 1.48% |
| Net interest margin (excluding PAA) (4) | **1.52%** | 1.51% | 1.50% |
| Average yield on interest earning assets | **3.23%** | 2.78% | 2.81% |
| Average yield on interest earning assets (excluding PAA) (4) | **3.17%** | 2.94% | 2.83% |
| Average cost of interest bearing liabilities (6) | **2.04%** | 1.75% | 1.62% |
| Net interest spread | **1.19%** | 1.03% | 1.19% |
| Net interest spread (excluding PAA) (4) | **1.13%** | 1.19% | 1.21% |
| Constant prepayment rate | **9.3%** | 10.6% | 13.3% |
| Long-term constant prepayment rate | **10.1%** | 10.4% | 10.1% |
| Common stock book value per share | **$9.39** | $11.34 | $11.16 |
| Interest income (excluding PAA) (4) | **$3,270,542** | $2,634,962 | $2,229,892 |
| Economic interest expense (4) (6) | **$1,797,307** | $1,334,093 | $1,085,118 |
| Economic net interest income (excluding PAA) (4) | **$1,473,235** | $1,300,869 | $1,144,774 |
| Core earnings (4) | **$1,636,941** | $1,267,160 | $1,194,884 |
| Premium amortization adjustment cost (benefit) | **$(62,021)** | $141,836 | $18,941 |
| Core earnings (excluding PAA) (4) | **$1,574,920** | $1,408,996 | $1,213,825 |
| Core earnings per common share (4) | **$1.25** | $1.09 | $1.15 |
| PAA cost (benefit) per common share (4) | **$(0.05)** | $0.13 | $0.02 |
| Core earnings (excluding PAA) per common share (4) | **$1.20** | $1.22 | $1.17 |

(1) Debt consists of repurchase agreements, other secured financing, debt issued by securitization vehicles and mortgages payable. Debt issued by securitization vehicles, certain credit facilities (included within other secured financing), and mortgages payable are non-recourse to us.

(2) Computed as the sum of Recourse Debt, TBA derivative and CMBX notional outstanding and net forward purchases (sales) of investments divided by total equity.

(3) Calculated as total stockholders’ equity divided by total assets inclusive of outstanding market value of TBA positions and exclusive of consolidated VIEs.

(4) Represents a non-GAAP financial measure. Refer to the “Non-GAAP Financial Measures” section for additional information.

(5) Represents the sum of our interest income plus TBA dollar roll income and CMBX coupon income less interest expense and the net interest component of interest rate swaps divided by the sum of average Interest Earning Assets plus average outstanding TBA contract and CMBX balances.

(6) Average cost on interest bearing liabilities represents annualized economic interest expense divided by average interest bearing liabilities. Average interest bearing liabilities reflects the average amortized cost during the period. Economic interest expense is comprised of GAAP interest expense and the net interest component of interest rate swaps. Prior to the quarter ended March 31, 2018, this metric included the net interest component of interest rate swaps used to hedge cost of funds. Beginning with the quarter ended March 31, 2018, as a result of changes to the Company’s hedging portfolio, this metric reflects the net interest component of all interest rate swaps.

#### 2018 Compared with 2017

#### GAAP

Net income (loss) was $54.1 million, which includes ($0.3) million attributable to noncontrolling interests, or ($0.06) per average basic common share, for the year ended December 31, 2018 compared to $1.6 billion, which includes ($0.6) million attributable to noncontrolling interests, or $1.37 per average basic common share, for the same period in 2017. We attribute the majority of the change in net income (loss) to the increase in net losses on disposal of investments and the unfavorable change in net gains (losses) on other derivatives, partially offset by the favorable change in the net interest component of interest rate swaps. Net losses on disposal of investments was ($1.1) billion for the year ended December 31, 2018 compared to ($3.9) million for the same period in 2017. Net losses on other derivatives was ($403.0) million for the year ended December 31, 2018 compared to net gains of $261.4 million for the same period in 2017. The net interest component of interest rate swaps was $100.6 million for the year ended December 31, 2018 compared with ($371.1) million for the same period in 2017. Refer to the section titled “Realized and Unrealized Gains (Losses)” located within this Item 7 for additional information related to these changes.

#### Non-GAAP

Core earnings (excluding premium amortization adjustment (“PAA”)) were $1.6 billion, or $1.20 per average common share, for the year ended December 31, 2018, compared to $1.4 billion, or $1.22 per average common share, for the same period in 2017. Core earnings (excluding PAA) increased during the year ended December 31, 2018 compared to the same period in 2017 primarily due to higher coupon income earned resulting from an increase in average Interest Earning Assets and favorable changes in the net interest component of interest rate swaps, partially offset by an increase in interest expense from higher borrowing rates and an increase in average Interest Bearing Liabilities.

#### 2017 Compared with 2016

#### GAAP

Net income (loss) was $1.6 billion, which includes ($0.6) million attributable to noncontrolling interests, or $1.37 per average basic common share, for the year ended December 31, 2017 compared to $1.4 billion, which includes ($1.0) million attributable to noncontrolling interests, or $1.39 per average basic common share, for the same period in 2016. We attribute the majority of the change in net income (loss) to an increase in unrealized gains on interest rate swaps and the lower net interest component of interest rate swaps, partially offset by the change in net unrealized gains (losses) on instruments measured at fair value through earnings and lower net interest income during the year ended December 31, 2017 compared to the same period in 2016. Unrealized gains on interest rate swaps were $512.9 million for the year ended December 31, 2017 compared with $282.2 million for the same period in 2016, reflecting a rise in forward interest rates during the year ended December 31, 2017 compared to lower forward rates during the same period in 2016. The net interest component of interest rate swaps decreased $135.6 million to ($371.1) million for the year ended December 31, 2017 reflecting lower net rates during the year ended December 31, 2017 compared to the same period in 2016. Net unrealized gains (losses) on instruments measured at fair value through earnings were ($39.7) million for the year ended December 31, 2017 compared to $86.4 million for the same period in 2016. The change was primarily due to unfavorable changes in unrealized gains (losses) on MSRs, partially offset by higher unrealized gains on non-Agency mortgage-backed securities and lower unrealized losses on Agency interest-only investments. Net interest income decreased $68.4 million to $1.5 billion for the year ended December 31, 2017, primarily due to higher cost of funds largely attributable to higher rates and higher average balances on repurchase agreements, partially offset by higher coupon income earned from an increase in average Interest Earning Assets for the year ended December 31, 2017 compared to the same period in 2016.

#### Non-GAAP

Core earnings (excluding premium amortization adjustment (“PAA”)) were $1.4 billion, or $1.22 per average basic common share, for the year ended December 31, 2017, compared to $1.2 billion, or $1.17 per average basic common share, for the same period in 2016. Core earnings increased during the year ended December 31, 2017 compared to the same period in 2016 primarily due to higher coupon income earned resulting from an increase in average Interest Earning Assets and the lower net interest component of interest rate swaps, partially offset by an increase in interest expense from higher rates and an increase in average Interest Bearing Liabilities.

### Non-GAAP Financial Measures

Beginning with the quarter ended September 30, 2018, we updated our calculation of core earnings and related metrics to reflect changes to our portfolio composition and operations, including the acquisition of MTGE in September 2018. Compared to prior periods, the revised definition of core earnings includes coupon income (expense) on CMBX positions (reported in Net gains (losses) on other derivatives) and excludes depreciation and amortization expense on real estate and related intangibles (reported

## Market risk

As filed, 216 characters.

Quantitative and qualitative disclosures about market risk are contained within the section titled “Risk Management” of Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

## Controls and procedures

As filed, 10,206 characters.

Our management, including our Chief Executive Officer (the CEO) and Chief Financial Officer (the CFO), reviewed and evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act) as of the end of the period covered by this report. Based on that review and evaluation, the CEO and CFO have concluded that our current disclosure controls and procedures, as designed, (1) were effective in ensuring that information required to be disclosed by the Company in reports it files or submits under the Securities Exchange Act is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure and (2) were effective in ensuring that information required to be disclosed by the Company in reports it files or submits under the Securities Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms.

There have been no changes in our internal controls over financial reporting that occurred during the three months ended December 31, 2018 that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.

### Management’s Annual Report On Internal Control Over Financial Reporting

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rules 13a-15(f) or 15d-15(f) under the Securities Exchange Act. Our internal control over financial reporting is a process designed by, or under the supervision of, the Company’s CEO and CFO and effected by the Company’s board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

- pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;
- provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts

and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

- provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. As a result, even systems determined to be effective can provide only reasonable assurance regarding the preparation and presentation of financial statements. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

The Company’s management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2018. In making this assessment, the Company’s management used criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission’s (“COSO”) Internal Control-Integrated Framework (2013). As permitted by the Securities and Exchange Commission guidelines that allow companies to exclude certain acquisitions from their assessment of internal control over financial reporting during the first year after acquisition, the scope of our evaluation excluded the internal controls of certain subsidiaries of Mountain Merger Sub Corporation (successor by merger to MTGE Investment Corp.), namely Annaly Healthcare Investments LLC (formerly Capital Healthcare Investments, LLC) and its subsidiaries, which constituted $321.6 million and $115.1 million of total assets and total equity, respectively, as of December 31, 2018, and $2.1 million of net income (loss) for the year then ended.

Based on the Company’s management’s evaluation under the framework in Internal Control—Integrated Framework (2013), the Company’s management concluded that its internal control over financial reporting was effective as of December 31, 2018. The Company’s independent registered public accounting firm, Ernst & Young LLP, has issued an attestation report on the Company’s internal control over financial reporting, which is included herein.

### Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors of

### Opinion on Internal Control over Financial Reporting

We have audited Annaly Capital Management, Inc. and Subsidiaries’ internal control over financial reporting as of December 31, 2018, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Annaly Capital Management, Inc. and Subsidiaries’ (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2018, based on the COSO criteria.

As indicated in the accompanying Management’s Annual Report on Internal Control over Financial Reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of certain subsidiaries of Mountain Merger Sub Corporation (successor by merger to MTGE Investment Corp.), namely Annaly Healthcare Investments LLC (formerly Capital Healthcare Investments, LLC) and its subsidiaries, which is included in the 2018 consolidated financial statements of the Company and constituted $321.6 million and $115.1 million of total assets and total equity, respectively, as of December 31, 2018, and $2.1 million of net income (loss) for the year then ended. Our audit of internal control over financial reporting of Annaly Capital Management, Inc. and Subsidiaries also did not include an evaluation of the internal control over financial reporting of certain subsidiaries of Mountain Merger Sub Corporation (successor by merger to MTGE Investment Corp.), namely Annaly Healthcare Investments LLC (formerly Capital Healthcare Investments, LLC) and its subsidiaries.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statements of financial condition of the Company as of December 31, 2018 and 2017, and the related consolidated statements of comprehensive income (loss), stockholders' equity and cash flows for each of the three years in the period ended December 31, 2018, the related notes, and financial statement schedules III and IV, and our report dated February 14, 2019 expressed an unqualified opinion thereon.

### Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Annual Report On Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

### Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Ernst & Young LLP

New York, NY

February 14, 2019

Filed Feb 15, 2019.
Source: SEC EDGAR, the filing index for accession 0001628280-19-001442. Last ingested by Listed: Nov 10, 2026, 02:34 ET. No prices; not investment advice.
